Investing
CapEx
Bristol-Myers Squibb CapEx decreased by 11.4% to $320.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 1.2%, from $324.00M to $320.00M. Over 3 years (FY 2021 to FY 2024), CapEx shows an upward trend with a 8.7% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
An increase signals growth investment or infrastructure modernization; a decrease might suggest cost-cutting or a transition to an asset-light model.
Detailed definition
Funds used by a company to acquire, upgrade, and maintain physical assets such as property, plants, buildings, technolog...
Peer comparison
Hardware-focused tech firms typically have higher CapEx relative to revenue than pure software companies due to manufacturing and supply chain needs.
Metric ID:
cf_capital_expendituresHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $210.00M | $270.00M | $320.00M | $253.00M | $272.00M | $247.00M | $346.00M | $278.00M | $259.00M | $342.00M | $330.00M | $284.00M | $262.00M | $324.00M | $378.00M | $260.00M | $361.00M | $320.00M |
| QoQ Change | — | +28.6% | +18.5% | -20.9% | +7.5% | -9.2% | +40.1% | -19.7% | -6.8% | +32.0% | -3.5% | -13.9% | -7.7% | +23.7% | +16.7% | -31.2% | +38.8% | -11.4% |
| YoY Change | — | — | — | — | +29.5% | -8.5% | +8.1% | +9.9% | -4.8% | +38.5% | -4.6% | +2.2% | +1.2% | -5.3% | +14.5% | -8.5% | +37.8% | -1.2% |
Range$210.00M – $378.00M
CAGR+10.4%
Avg YoY Growth+7.8%
Median YoY Growth+1.7%
CapEx at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's capex?
- Bristol-Myers Squibb (BMY) reported capex of $320.00M in Q3 2025.
- How has Bristol-Myers Squibb's capex changed year-over-year?
- Bristol-Myers Squibb's capex decreased by 1.2% year-over-year, from $324.00M to $320.00M.
- What is the long-term trend for Bristol-Myers Squibb's capex?
- Over 3 years (2021 to 2024), Bristol-Myers Squibb's capex has grown at a 8.7% compound annual growth rate (CAGR), from $973.00M to $1.25B.
- What does capex mean?
- The money spent on long-term physical assets like machinery, data centers, and office buildings.